The University of Oxford works with Chinese Medicine pharmaceutical to study the electrophysiological properties of Xin Su Ning

After a year’s communication, negotiation and discussion, on 17th October 2014 the University of Oxford and Shaanxi Momentum Pharmaceutical Co. Ltd signed a research agreement to study the electrophysiological properties of Xin Su Ning, an antiarrhythmic multi-herbal medicine produced and marketed in China by Shaanxi Momentum Pharmaceutical Co. Ltd. This is the first agreement of this kind, which the University of Oxford had signed with a China private Chinese medicine pharmaceutical. This research project will help Chinese medicine’s development in research that would lead to better understandings of the mechanism of its clinical efficacy in wider public and medical professions internationally, hence to make better contributions to the health care of mankind.

　　On the invitation of the Department of Physiology, Anatomy & Genetics, University of Oxford, Mr Wang Bao-An, the CEO of the Company; Mr Mao Peng, the Head of R&D of the Company; Professor Zhao Zheng-Sheng, Shanxi College of Chinese Medicine and Dr Zhang Xiao-Xiao, China Society of Chinese Medicine visited the University of Oxford from 16th October to 22nd October 2014. Apart from signing the research agreement, Mr Wang and his colleagues also discussed with internationally well-known experts in the Department on the details of the research project and the possibilities to form a research platform to facilitate long term collaboration between the company and the university.

　　Dr Yu-ling Ma, Department of Physiology, Anatomy and Genetics, University of Oxford, the project leader said that Professor Richard Vaughan-Jones, the President of the British Physiology Society and the Joint Director, Burdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, will act as an academic advisor for the project; Professor Peter Robbins, the head of the Department of Physiology, Anatomy and Genetics, and Dr Robert Wilkins and Professor Clive Ellory will give overall support of the project. The project has been signed for one year initially and the company is preparing a 5 year plan of research collaboration with the University of Oxford, and the university is very much interested in long term collaboration with Shaanxi Momentum Pharmaceutical.

　　Professor Richard Vaughan-Jones said that the emergence of systems biology helps the development of the study of Chinese medicine; the University of Oxford was one of the early initiators in the study of systems biology. With much interest he is looking forward to seeing the development of the collaborative research project with Shaanxi Momentum Pharmaceutical.

I am so glad to know that University of Oxford and Chinese Pharmaceuticals have signed a research agreement. This will definitely make contribution towards improving effectiveness of herbal medicines. My cousin took TCM Mississauga session and he got rid of his age old health problems.